Porter P J, Mazighi M, Rodesch G, Alvarez H, Aghakhani N, David P H, Lasjaunias P
Service de Neuroradiologie Diagnostic et Thérapeutique, Hôpital de Bicêtre, Le Kremlin Bicêtre, France.
Interv Neuroradiol. 2001 Dec 22;7(4):291-302. doi: 10.1177/159101990100700403. Epub 2002 Jan 10.
Patients with multiple intradural aneurysms present unique clinical challenges, particularly when presenting with subarachnoid haemorrhage. This study was undertaken to retrospectively review the management of such patients treated at a single institution. Consecutive patients with multiple intradural aneurysms managed at our institution between 1993 and 1999 were studied. The 122 patients had a total of 305 aneurysms. In most patients presenting with subarachnoid haemorrhage, the aneurysm responsible for the bleed could be identified with a fair degree of certainty, as confirmed by subsequent surgical and autopsy findings. Irregularity of the aneurysm (false sac or polylobulation) was the most useful criterion for making this determination. Failure to recognize all aneurysms on the original angiogram remained an uncommon but clinically important problem. Posterior inferior cerebellar and anterior communicating artery aneurysm locations were disproportionately more likely, and para-ophthalmic less likely, to be responsible for the subarachnoid haemorrhage. There was a trend for patients with uncertainty regarding the site of bleeding to have all aneurysms treated, and for cure to be obtained in a shorter time. Surgical and endovascular complication rates and patient outcomes were not dissimilar from what one would expect for single aneurysm patients. During follow-up, we observed a haemorrhage rate from unruptured aneurysms of 1.1% per patient-year of observation, and a de novo aneurysm formation rate of 0.76% of patients per year. In conclusion, we feel that although patients with multiple intradural aneurysms have more complex management issues than those with single aneurysms, good outcomes can be achieved with appropriate use of endovascular and/or surgical therapy. The goal in the acute setting following subarachnoid haemorrhage is recognition of all aneurysms and urgent treatment of the one responsible for the haemorrhage. When there is uncertainty, more than one aneurysm may need to be treated. Decisions on subsequent treatment of remaining unruptured aneurysms must be individualized.
患有多个硬脊膜内动脉瘤的患者面临着独特的临床挑战,尤其是在出现蛛网膜下腔出血时。本研究旨在回顾性分析在单一机构接受治疗的此类患者的治疗情况。对1993年至1999年间在我们机构接受治疗的连续性多个硬脊膜内动脉瘤患者进行了研究。122例患者共有305个动脉瘤。在大多数出现蛛网膜下腔出血的患者中,后续手术和尸检结果证实,可相当确定地识别出导致出血的动脉瘤。动脉瘤的不规则性(假性动脉瘤或多叶状)是做出这一判断最有用的标准。未能在初次血管造影时识别出所有动脉瘤仍是一个不常见但临床上很重要的问题。小脑后下动脉和前交通动脉动脉瘤部位导致蛛网膜下腔出血的可能性不成比例地更高,而眼旁动脉瘤导致出血的可能性较小。对于出血部位不确定的患者,有将所有动脉瘤都进行治疗的趋势,并且能在更短时间内实现治愈。手术和血管内治疗的并发症发生率以及患者的预后与单个动脉瘤患者的预期情况并无不同。在随访期间,我们观察到未破裂动脉瘤的出血率为每位患者每年观察期1.1%,每年新发动脉瘤形成率为患者的0.76%。总之,我们认为,尽管患有多个硬脊膜内动脉瘤的患者比单个动脉瘤患者有更复杂的治疗问题,但通过适当使用血管内和/或手术治疗可取得良好预后。蛛网膜下腔出血后急性期的目标是识别所有动脉瘤并紧急治疗导致出血的动脉瘤。当存在不确定性时,可能需要治疗不止一个动脉瘤。关于其余未破裂动脉瘤后续治疗的决策必须个体化。